artificial intelligence

Armed with improved imaging techniques and supercomputers, researchers are generating detailed three-dimensional images of cellular structures that anyone can explore.

The AlphaFold program from AI firm DeepMind has amassed a huge database of protein structures from humans and model organisms.

Automated control of light-responsive nematode worms marks the first foray into the development of multicellular, biorobotic organisms.

The experimental system, developed and tested in just one patient so far, relies on brain signals associated with handwriting to achieve the fastest communication yet seen with BCI.

While machine learning could improve detection of tumors at their earliest stages, it also risks identifying malignancies that would never cause the patient any harm.

Good girl, Florin!

In a proof-of-concept study, researchers used dogs’ diagnoses of prostate cancer to inform a machine learning algorithm with the goal of one day detecting cancers with canine-level accuracy.

Some researchers have turned their focus to artificial intelligence to study an underused symptom common to most respiratory pathogens—cough.

The technology solves proteins’ 3-D shapes in minutes, when traditional methods may take years.

A small study shows artificial intelligence can pick out individuals with coronavirus infections, but ophthalmologists and AI experts say the approach is far from proven to be capable of distinguishing infections with SARS-CoV-2 from other ills.

More than 3,000 researchers have signed on to a petition that expresses concern over the agency’s 2021 application for the funding program, which emphasizes three areas of computational science and might further disadvantage underrepresented groups.

Researchers try unprecedented data sharing and cooperation to understand COVID-19—and develop a model for diseases beyond the coronavirus pandemic.

The open access publication will use AI to identify the most pressing manuscripts in need of peer review.

Machine learning has pegged existing drugs to repurpose for COVID-19 clinical trials.

The technology, tested out on patients with epilepsy who already had electrodes implanted in their brains, is currently limited to 30–50 sentences.

Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.

Researchers used a machine-learning platform to test more than 100 million molecules for antibacterial activity.